Pharmaust Phase II K9 Trial, page-471

I think this is more of a case of science frustration the investor rather than anything insidious.
I'm sure they have a program that they are following to make sure the trials are a success. I would prefer that to rushing something that could lead to questionable results. They said end of year, its still Oct.
Having said that, a little update would be appreciated but I would not be thinking of starting a revolution in the boardroom when the share price has rising from .025 to .115 in a few months with trials underway. Just my thoughts but I cant see the reasons for all the panicky messages.
Unless, there's a deepset mistrust in management which if this were 80% of the ASX I could understand but I'm not feeling it in this case.